Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

Granzyme B ELISPOT assay to measure influenza-specific cellular immunity.

Salk HM, Haralambieva IH, Ovsyannikova IG, Goergen KM, Poland GA.

J Immunol Methods. 2013 Dec 15;398-399:44-50. doi: 10.1016/j.jim.2013.09.007. Epub 2013 Sep 18.

PMID:
24055591
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Granzyme B: Correlates with protection and enhanced CTL response to influenza vaccination in older adults.

McElhaney JE, Ewen C, Zhou X, Kane KP, Xie D, Hager WD, Barry MB, Kleppinger A, Wang Y, Bleackley RC.

Vaccine. 2009 Apr 21;27(18):2418-25. doi: 10.1016/j.vaccine.2009.01.136. Epub 2009 Mar 3.

PMID:
19368783
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Detection of influenza A/H1N1-specific human IgG-secreting B cells in older adults by ELISPOT assay.

Painter SD, Haralambieva IH, Ovsyannikova IG, Grill DE, Poland GA.

Viral Immunol. 2014 Mar;27(2):32-8. doi: 10.1089/vim.2013.0099.

PMID:
24605786
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

The cell-mediated cytotoxic response to influenza vaccination using an assay for granzyme B activity.

McElhaney JE, Pinkoski MJ, Upshaw CM, Bleackley RC.

J Immunol Methods. 1996 Mar 28;190(1):11-20.

PMID:
8601703
[PubMed - indexed for MEDLINE]
5.

Effect of congestive heart failure on humoral and ex vivo cellular immune responses to influenza vaccination in older adults.

McElhaney JE, Herre JM, Lawson ML, Cole SK, Burke BL, Hooton JW.

Vaccine. 2004 Jan 26;22(5-6):681-8.

PMID:
14741160
[PubMed - indexed for MEDLINE]
6.

Comparison of neutralizing antibody and cell-mediated immune responses to pandemic H1N1 2009 influenza virus before and after H1N1 2009 influenza vaccination of elderly subjects and healthcare workers.

Hsu JP, Phoon MC, Koh GC, Chen MI, Lee VJ, Wu Y, Xie ML, Cheong A, Leo YS, Chow VT.

Int J Infect Dis. 2012 Aug;16(8):e621-7. doi: 10.1016/j.ijid.2012.04.010. Epub 2012 Jun 15.

PMID:
22704721
[PubMed - indexed for MEDLINE]
Free Article
7.

High proportions of regulatory B and T cells are associated with decreased cellular responses to pH1N1 influenza vaccine in HIV-infected children and youth (IMPAACT P1088).

Weinberg A, Muresan P, Fenton T, Richardson K, Dominguez T, Bloom A, Petzold E, Anthony P, Cunningham CK, Spector SA, Nachman S, Siberry GK, Handelsman E, Flynn PM; IMPAACT P1088 study team.

Hum Vaccin Immunother. 2013 May;9(5):957-68. doi: 10.4161/hv.23774. Epub 2013 Jan 31.

PMID:
23370281
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Humoral and cellular immune response to influenza virus vaccination in aged humans.

Fagiolo U, Amadori A, Cozzi E, Bendo R, Lama M, Douglas A, Palù G.

Aging (Milano). 1993 Dec;5(6):451-8.

PMID:
8161577
[PubMed - indexed for MEDLINE]
9.

Humoral and cellular responses to a non-adjuvanted monovalent H1N1 pandemic influenza vaccine in hospital employees.

Herrera MT, Gonzalez Y, Juárez E, Hernández-Sánchez F, Carranza C, Sarabia C, Guzman-Beltran S, Manjarrez ME, Muñoz-Torrico M, Garcia-Garcia L, Sada E, Torres M.

BMC Infect Dis. 2013 Nov 15;13:544. doi: 10.1186/1471-2334-13-544.

PMID:
24238117
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Pitfalls in anti-influenza T cell detection by Elispot using thimerosal containing pandemic H1N1 vaccine as antigen.

Chauvat A, Benhamouda N, Loison E, Gougeon ML, Gey A, Levionnois E, Ravel P, Abitbol V, Roncelin S, Marcheteau E, Quintin-Colonna F, Fridman WH, Launay O, Tartour E.

J Immunol Methods. 2012 Apr 30;378(1-2):81-7. doi: 10.1016/j.jim.2012.02.008. Epub 2012 Feb 16.

PMID:
22366633
[PubMed - indexed for MEDLINE]
11.
12.

Long-term persistence of humoral and cellular immune responses induced by an AS03A-adjuvanted H1N1 2009 influenza vaccine: an open-label, randomized study in adults aged 18-60 years and older.

Van Damme P, Kafeja F, Bambure V, Hanon E, Moris P, Roman F, Gillard P.

Hum Vaccin Immunother. 2013 Jul;9(7):1512-22. doi: 10.4161/hv.24504. Epub 2013 Apr 9.

PMID:
23571166
[PubMed - indexed for MEDLINE]
13.

Antibody but not memory B-cell responses are tuned-down in vertically HIV-1 infected children and young individuals being vaccinated yearly against influenza.

Rinaldi S, Zangari P, Cotugno N, Manno EC, Brolatti N, Castrucci MR, Donatelli I, Rossi P, Palma P, Cagigi A.

Vaccine. 2014 Feb 3;32(6):657-63. doi: 10.1016/j.vaccine.2013.12.008. Epub 2013 Dec 13.

PMID:
24333344
[PubMed - indexed for MEDLINE]
14.

A non-living nasal influenza vaccine can induce major humoral and cellular immune responses in humans without the need for adjuvants.

Samdal HH, Bakke H, Oftung F, Holst J, Haugen IL, Korsvold GE, Kristoffersen AC, Krogh G, Nord K, Rappuoli R, Berstad AK, Haneberg B.

Hum Vaccin. 2005 Mar-Apr;1(2):85-90. Epub 2005 Mar 16.

PMID:
17038826
[PubMed - indexed for MEDLINE]
Free Article
15.

Preserved antigen-specific immune response in patients with multiple sclerosis responding to IFNβ-therapy.

Mehling M, Fritz S, Hafner P, Eichin D, Yonekawa T, Klimkait T, Lindberg RL, Kappos L, Hess C.

PLoS One. 2013 Nov 5;8(11):e78532. doi: 10.1371/journal.pone.0078532. eCollection 2013.

PMID:
24223820
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Helper and cytotoxic T lymphocyte responses to influenza vaccination in healthy compared to diabetic elderly.

McElhaney JE, Pinkoski MJ, Au D, Lechelt KE, Bleackley RC, Meneilly GS.

Vaccine. 1996 Apr;14(6):539-44.

PMID:
8782353
[PubMed - indexed for MEDLINE]
17.

ELISpot assay as a sensitive tool to detect cellular immunity following influenza vaccination in kidney transplant recipients.

Lindemann M, Witzke O, Lütkes P, Fiedler M, Kreuzfelder E, Philipp T, Roggendorf M, Grosse-Wilde H.

Clin Immunol. 2006 Sep;120(3):342-8. Epub 2006 Apr 21.

PMID:
16631409
[PubMed - indexed for MEDLINE]
18.

The human potential of a recombinant pandemic influenza vaccine produced in tobacco plants.

Jul-Larsen Å, Madhun AS, Brokstad KA, Montomoli E, Yusibov V, Cox RJ.

Hum Vaccin Immunother. 2012 May;8(5):653-61. doi: 10.4161/hv.19503. Epub 2012 May 1.

PMID:
22634440
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Optimal vaccination strategies for 2009 pandemic H1N1 and seasonal influenza vaccines in humans.

Wu J, Zhong X, Li CK, Zhou JF, Lu M, Huang KY, Dong M, Liu Y, Luo FJ, Du N, Chui C, Liu LQ, Smith NM, Li B, Shi NM, Song LF, Gao Y, Wang DY, Wang X, Zhu WF, Yan Y, Li Z, Chen JT, McMichael AJ, Yin WD, Xu XN, Shu Y.

Vaccine. 2011 Jan 29;29(5):1009-16. doi: 10.1016/j.vaccine.2010.11.058. Epub 2010 Dec 2.

PMID:
21130194
[PubMed - indexed for MEDLINE]
20.

A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults.

Talaat KR, Karron RA, Callahan KA, Luke CJ, DiLorenzo SC, Chen GL, Lamirande EW, Jin H, Coelingh KL, Murphy BR, Kemble G, Subbarao K.

Vaccine. 2009 Jun 8;27(28):3744-53. doi: 10.1016/j.vaccine.2009.03.082. Epub 2009 Apr 17.

PMID:
19464558
[PubMed - indexed for MEDLINE]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk